CompletedNot Applicable

Acceptability and Efficacy of Zemedy App Versus Education and Relaxation Training App for IBS

United States453 participantsStarted 2021-03-01

Plain-language summary

The purpose of this research is to assess if a new digital app version of a self-help intervention for Irritable Bowel Syndrome (IBS), is an acceptable and effective treatment for improving the overall quality of life in patients with IBS.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Self-report of physician diagnosis of IBS. * At least 18 years of age. Exclusion Criteria: * Severe depression or suicidality * Comorbid GI disorder such as inflammatory bowel disease or celiac disease. * Pregnancy

What they're measuring

Irritable Bowel Syndrome Quality of Life (IBSQoL)

Timeframe: 8 weeks

Gastrointestinal Symptom Rating Scale (GSRS)

Timeframe: 8 weeks

Trial details

NCT IDNCT04665271

SponsorUniversity of Pennsylvania

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-30

View on ClinicalTrials.gov More Irritable Bowel Syndrome trials